A United Kingdom supplier, with 2 awarded contracts, totalling £248.5m, most recently 10 months ago.
This contract involves the supply of the medication TALKVETAMAB to the General University Hospital in Prague. Suppliers are invited to review the detailed procurement conditions for more information.
This public procurement contract involves the ongoing supply of pharmaceutical products that meet the requirements set by the State Institute for Drug Control (SÚKL) and contain the active ingredient daratumumab. The contract is valued at approximately 209 million CZK and is intended for the health
